Hemab Therapeutics raised €127M in a Series B round in Feb 2023. The company is based in Copenhagen, Denmark. Investors in the round: Access Biotechnology, Avoro Ventures, Deep Track Capital and 6 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
